Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
QUALE ITER DIAGNOSTICO NEI LUNGO VIVENTI AL CANCRO CON DOLORE TORACICO? DESCRIZIONE DI UN CASO CLINICO
Anno:
2023
Introduzione Cancro e Malattie CV condividono spesso fattori di rischio e meccanismi fisiopatologici comuni, la relazione può essere amplificato dal trattamento oncologico. Nel caso degli inibitori dell’aromatasi (IA), utilizzati per lungo tempo nel cancro mammario (CM) che esprime il recettore per gli estrogeni vi è una associazione significativa con…
LEFT ATRIAL AND VENTRICULAR STRAIN, AND 3D-ECHOCARDIOGRAPHY FOR SUBCLINICAL CHEMOTHERAPY-RELATED CARDIAC DYSFUNCTION IDENTIFICATION IN PATIENTS WITH BREAST CANCER
Anno:
2023
Cardio-oncology is a recent rapid-developing multidisciplinary approach created by oncologists in accordance with cardiologists with the objective to minimize the adverse cardiovascular effects of contemporary cancer therapy and to maximize the benefits that can be obtained from it. Pre-treatment cancer therapy-related cardiovascular toxicity (CTR-CVT) risk assessment can be performed…
TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE-CHALLENGE OF DOUBLE ANTI-HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES
Anno:
2023
INTRODUCTION Cardiovascular diseases (CVD) and Cancer (C), the most important causes of mortality worldwide. share many risk factors and common pathophysiological processes such as chronic inflammation and unfavorable cardio-metabolic profile. Progress in oncological treatments improved the survival of oncological patients (Pt) but have increased the likelihood of short- and…